DeutschNewstral
Article
jdsupra.com on 2017-12-12 21:32
Magistrate Judge Recommends Dismissal of Amgen v. Coherus (Pegfilgrastim) Suit
Related news
- Coherus Files Responsive Appellate Brief in Amgen v. Coherus (pegfilgrastim)jdsupra.com
- Update: Coherus’ Motion to Stay Discovery in Amgen v. Coherusjdsupra.com
- Coherus Requests Stay Of Discovery in Amgen v. Coherusjdsupra.com
- Amgen v. Sandoz: Pegfilgrastim Litigation Updatejdsupra.com
- Updates on Coherus pegfilgrastim and other biosimilar effortsjdsupra.com
- Coherus Receives FDA’s Complete Response Letter for its Pegfilgrastim Biosimilarjdsupra.com
- Coherus Biosciences Announces Approval of a Pegfilgrastim Autoinjectorjdsupra.com
- New BPCIA Litigation: Amgen v. Coherus (D. Del.)jdsupra.com
- Amgen Sues Sandoz Over Biosimilar Version of NEULASTA® (pegfilgrastim)jdsupra.com
- Amgen Sues Coherus Under BPCIA After Completing Patent Dancejdsupra.com
- Summary Judgment Practice Scheduled in Amgen v. Hospira Pegfilgrastim Casejdsupra.com
- Coherus Settles with AbbVie, and Sues Amgen, Over Adalimumab Biosimilarsjdsupra.com
- Updates on Sandoz’s Pegfilgrastim Biosimilar / Amgen v. Sandozjdsupra.com
- Coherus Implements Restructuring Plan Following Complete Response Letter For Its Pegfilgrastim Biosimilarjdsupra.com
- Amgen and Accord End Filgrastim, Pegfilgrastim Biosimilar Litigationjdsupra.com
- Coherus Announces Marketing Authorization Application to the EMA for Pegfilgrastim Biosimilarjdsupra.com
- Coherus and Amgen Stipulate to Dismissal of Adalimumab Infringement Casejdsupra.com
- Amgen v. Apotex: Amgen Appeals Non-Infringement Judgment in Filgrastim/Pegfilgrastim Disputejdsupra.com
- Litigation Update: Case Management Statement in Amgen v. Sandoz (filgrastim, pegfilgrastim)jdsupra.com
- Coherus Settles with AbbVie, and Sues Amgen, Over Adalimumab Biosimilars (Updated)jdsupra.com